Study on Efflux Pump Inhibition Activity of Marine Actinomycetes against Oflaxcin Resistsnt M. tuberculosis

Autores

  • Gajalakshmi P DEPARTMENT OF MICROBIOLOGY, DHANALAKSHMI SRINIVASAN COLLEGE OF ARTS AND SCIENCE FOR WOMEN PERAMBALUR 621212 TAMIL NADU INDIA
  • Raja A
  • Arthur James R

Resumo

Studies were conducted to isolate marine actinomycetes active against oflaxcin resistant M. tuberculosis. Out of 25 actinomycetes isolates designated as ECRMP 4 showed potent antimycobacterial activity against all three tested Mycobacterial strains. Representative bioactive isolate was characterized using phenotypic property and identified as Micropolyspora sp. The zone of inhibition was 20 ± 0.1 mm (62% RIZD) against M. tuberculosis and 18 ± 0.6 mm (100% RIZD) against OFLR M. tuberculosis. The bioassay of crude compound prevails that the Rf value of compound is 0.16. In this study we evaluated the role of the efflux pumps in quinolone resistance by using carbonyl cyanide m-chlorophenyl hydrazone (CCCP), 2,4-dinitrophenol (DNP) and verapamil against clinical isolate of M. tuberculosis. The MIC levels of OFL showed twofold reductions in presence of CCCP, verapamil and DNP while in case of ECRMP 4 Micropolyspora sp. metabolite showed fourfold reductions in MIC. These finding suggest the involvement of active efflux pumps activity of isolated compound from Micropolyspora can be able to produce noval antimycobacterial molecules. Keywords: Micropolyspora, oflaxcin, relative zone of inhibition, efflux pump

Biografia do Autor

  • Gajalakshmi P, DEPARTMENT OF MICROBIOLOGY, DHANALAKSHMI SRINIVASAN COLLEGE OF ARTS AND SCIENCE FOR WOMEN PERAMBALUR 621212 TAMIL NADU INDIA
    assistant professordepartment of microbiology

Downloads

Publicado

2014-09-26

Edição

Vol. 4 N.º 2 (2014)

Secção

Research Articles

Licença

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

·         I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.

·         I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).

·         I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.

·          I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

_______________

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.